NCT03835533 2024-04-12PORTERParker Institute for Cancer ImmunotherapyPhase 1 Completed43 enrolled 19 charts
NCT03745807 2021-10-04An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid TumorsBristol-Myers SquibbPhase 1 Completed3 enrolled